[go: up one dir, main page]

DK0906107T3 - Formuleringer indeholdende VX478 og en vandopløselig Vitamin E-forbindelse såsom Vitamin E-TPGS - Google Patents

Formuleringer indeholdende VX478 og en vandopløselig Vitamin E-forbindelse såsom Vitamin E-TPGS

Info

Publication number
DK0906107T3
DK0906107T3 DK97914287T DK97914287T DK0906107T3 DK 0906107 T3 DK0906107 T3 DK 0906107T3 DK 97914287 T DK97914287 T DK 97914287T DK 97914287 T DK97914287 T DK 97914287T DK 0906107 T3 DK0906107 T3 DK 0906107T3
Authority
DK
Denmark
Prior art keywords
vitamin
tpgs
compound
water
formulations containing
Prior art date
Application number
DK97914287T
Other languages
English (en)
Inventor
Arup K Roy
Lloyd Gary Tillman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606372.2A external-priority patent/GB9606372D0/en
Priority claimed from US08/820,848 external-priority patent/US6730679B1/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority claimed from PCT/EP1997/001438 external-priority patent/WO1997035587A1/en
Application granted granted Critical
Publication of DK0906107T3 publication Critical patent/DK0906107T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK97914287T 1996-03-22 1997-03-21 Formuleringer indeholdende VX478 og en vandopløselig Vitamin E-forbindelse såsom Vitamin E-TPGS DK0906107T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1389396P 1996-03-22 1996-03-22
GBGB9606372.2A GB9606372D0 (en) 1996-03-26 1996-03-26 Pharmaceutical formulations
US08/820,848 US6730679B1 (en) 1996-03-22 1997-03-20 Pharmaceutical formulations
PCT/EP1997/001438 WO1997035587A1 (en) 1996-03-22 1997-03-21 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs

Publications (1)

Publication Number Publication Date
DK0906107T3 true DK0906107T3 (da) 2003-05-05

Family

ID=27268205

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97914287T DK0906107T3 (da) 1996-03-22 1997-03-21 Formuleringer indeholdende VX478 og en vandopløselig Vitamin E-forbindelse såsom Vitamin E-TPGS

Country Status (23)

Country Link
EP (1) EP0906107B1 (da)
CN (1) CN1225587A (da)
AP (1) AP1150A (da)
AT (1) ATE230602T1 (da)
AU (1) AU724239B2 (da)
BR (1) BR9708238A (da)
CA (1) CA2249336C (da)
CY (1) CY2444B1 (da)
CZ (1) CZ289958B6 (da)
DE (1) DE69718315T2 (da)
DK (1) DK0906107T3 (da)
EA (1) EA001484B1 (da)
EE (1) EE04093B1 (da)
ES (1) ES2190528T3 (da)
GE (1) GEP20012464B (da)
IS (1) IS2066B (da)
NO (1) NO317639B1 (da)
NZ (1) NZ331645A (da)
RO (1) RO119923B1 (da)
SI (1) SI0906107T1 (da)
SK (1) SK284244B6 (da)
TR (1) TR199801881T2 (da)
UY (1) UY25926A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114366808B (zh) * 2021-12-14 2023-10-13 南京农业大学 一种多糖和病毒抗原共递送纳米疫苗、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
JPH11505257A (ja) * 1995-05-19 1999-05-18 アボツト・ラボラトリーズ 親油性薬物の自己乳化性製剤

Also Published As

Publication number Publication date
DE69718315D1 (de) 2003-02-13
AU724239B2 (en) 2000-09-14
EP0906107A1 (en) 1999-04-07
CY2444B1 (en) 2004-11-12
CA2249336A1 (en) 1997-10-02
SK284244B6 (sk) 2004-12-01
BR9708238A (pt) 1999-08-03
NO984386L (no) 1998-11-20
CZ303598A3 (cs) 1999-03-17
IS4840A (is) 1998-08-28
GEP20012464B (en) 2001-06-25
CZ289958B6 (cs) 2002-05-15
HK1016896A1 (en) 1999-11-12
AP9801343A0 (en) 1998-09-30
ATE230602T1 (de) 2003-01-15
EP0906107B1 (en) 2003-01-08
NZ331645A (en) 2000-02-28
ES2190528T3 (es) 2003-08-01
TR199801881T2 (xx) 1999-01-18
AP1150A (en) 2003-03-14
CN1225587A (zh) 1999-08-11
DE69718315T2 (de) 2003-10-30
SI0906107T1 (en) 2003-08-31
IS2066B (is) 2005-11-15
AU2159197A (en) 1997-10-17
NO984386D0 (no) 1998-09-21
SK126998A3 (en) 1999-10-08
NO317639B1 (no) 2004-11-29
UY25926A1 (es) 2000-09-29
CA2249336C (en) 2005-11-22
EE9800323A (et) 1999-04-15
EE04093B1 (et) 2003-08-15
EA199800755A1 (ru) 1999-06-24
RO119923B1 (ro) 2005-06-30
EA001484B1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
TR199501632A1 (tr) Toz formülasyonlari.
FI982009L (fi) Propofolin mikropisaraformulaatioita
EE9700138A (et) Aerosoolravimvormid
MA24473A1 (fr) Formulations
ID23299A (id) Formulasi-formulasi farmasi
NO20004721D0 (no) Bruseformuleringer
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
NO943264D0 (no) Naturlig vitamin E-preparat
FI941447L (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
NO991771D0 (no) Sprengstoff-formuleringer
TR199501082A2 (tr) Farmasötik formülasyonlar.
DK0861025T3 (da) Pesticidformuleringer
ITMI941169A0 (it) Formulazioni farmaceutiche
NO20005722D0 (no) Brusetilberedninger
EP0837863A4 (en) DISODIUM ALENDRONATE PREPARATIONS
DE59812037D1 (de) Insektizid-enthaltende formulierungen
DK0906107T3 (da) Formuleringer indeholdende VX478 og en vandopløselig Vitamin E-forbindelse såsom Vitamin E-TPGS
DK0944313T3 (da) Insekticide og miticide sammensætninger
NO983556L (no) Formulering og anvendelse
NO991430D0 (no) Insektfordrivende formuleringer
NO985110D0 (no) Eksplosivformuleringer
NO985112D0 (no) Eksplosivformuleringer
BR1100596A (pt) Composto e formulações farmacêuticas